We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Biotech IPOs steam ahead in 2014.
- Authors
Burrill, G. Steven
- Abstract
The article discusses the economic aspects of Initial public offering (IPO) for the U.S. biotechnology companies as of March 2014. Topics discussed include biotech IPO market, drug approvals and U.S. Food and Drug Administration. It also offers information related to several companies that launched their IPOs in 2014 including Dicerna Pharmaceuticals, UltraGenyx Pharmaceuticals and Auspex Pharmaceuticals.
- Subjects
GOING public (Securities); CORPORATE finance; BIOTECHNOLOGY industries; AUSPEX Pharmaceuticals Inc.; ULTRAGENYX Pharmaceutical Inc.; DICERNA Pharmaceuticals Inc.; ECONOMICS
- Publication
Journal of Commercial Biotechnology, 2014, Vol 20, Issue 2, p48
- ISSN
1462-8732
- Publication type
Article
- DOI
10.5912/jcb654